Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Alzheimer's disease (AD) has a strong genetic predisposition. Genome-wide association studies have identified multiple risk loci, yet many non-coding variants remain uncharacterized. Machine learning-based polygenic risk scores (PRS) enhance prediction by modeling genetic epistasis and sex-specific risks. This review summarizes AD genetic risk factors, PRS methodologies, and ML-based AD risk predi...
BACKGROUND: Plasma biomarkers have emerged as robust indicators of Alzheimer's disease (AD) pathology, offering accessible tools for staging and stratification. However, their expression across globally diverse populations remains poorly characterized. The aim of this study was to evaluate whether the combination of plasma biomarkers could distinguish different stages along the AD continuum and as...
BACKGROUND: Epigenetic modifications play a vital role in the pathogenesis of human diseases, particularly neurodegenerative disorders such as Alzheim...
Alzheimer's disease (AD) is the most common type of dementia, accounting for at least two-thirds of dementia cases in people aged 65 and older. Numero...
Oxidative stress is a central pathogenic process in the earliest stages of Alzheimer's disease (AD), promoting non-enzymatic protein modifications tha...
BACKGROUND: Prolonged Grief Disorder (PGD) in later life may involve volumetric patterns indicative of accelerated brain aging. This study examined wh...
Alzheimer's disease and related dementias (ADRD) remain underdiagnosed early due to reliance on costly, invasive, and time-intensive assessments, prom...
BACKGROUND AND OBJECTIVES: CONFIDENCE is a culturally tailored intervention to reduce caregiver financial strain, which disproportionately impacts Lat...
BACKGROUND: Psychological distress, particularly symptoms of depression and anxiety (D&A), is highly prevalent among family caregivers of individuals ...
Differentiating between Alzheimer's disease (AD), frontotemporal dementia (FTD), and cognitively normal (CN) subjects remains a significant challenge ...
The genetic mechanisms of ~90% of Alzheimer's disease (AD)-associated variants residing in noncoding DNA remain poorly understood. To address this, we...
BACKGROUND: This study aims to investigate the association between leukocyte telomere length (LTL) and the risk of incident NDDs using a large-scale c...
Early identification of infants and toddlers at risk for developmental disorders can improve the efficiency of early intervention programs and can red...
Alzheimer's disease (AD) requires the discovery of new therapeutic targets, but traditional molecular docking methods for virtual screening are often ...
This study aims to synthesize the perceptions and expectations of long-term caregivers regarding the use of nursing robots to inform strategies for en...
Neuroanatomical heterogeneity in Alzheimer's disease (AD) hinders precision diagnosis and treatment, as distinct brain phenotypes may correspond to di...
Neural architecture search (NAS) automates neural network design, improving efficiency over manual approaches. However, efficiently discovering high-p...
Alzheimer's disease (AD), a type of neurodegenerative disorder, has seen an increase in cases over the past decade, necessitating the construction of ...
STUDY OBJECTIVES: The rich information in sleep offers insights into brain function and overall health. The current guidelines for sleep staging by th...
This study aimed to explore the underlying mechanisms and key targets of widely used plasticizers, including dimethyl phthalate (DMP), diethyl phthala...